07:00 , Jun 10, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Depression; mania Kinesin light chain 2 (KLC2); glycogen synthase kinase 3b (GSK3B); AMPA 1 glutamate receptor (GRIA1; GLUR); GRIA2 (GLUR2) In vitro and mouse studies...